Search

Displaying results 391 - 400 of 7022 in total
  1. Indication

    Mutations amenable to exon 45 skipping

    go.drugbank.com/conditions/DBCOND0137287
    Drugs: Casimersen
    Synonyms: Mutations amenable to exon 45 skipping
  2. Indication

    Mutations amenable to exon 51 skipping

    go.drugbank.com/conditions/DBCOND0145702
    Drugs: Eteplirsen
    Synonyms: Mutations amenable to exon 51 skipping
  3. Indication

    Mild to moderate distal ulcerative colitis

    go.drugbank.com/conditions/DBCOND0100450
    Drugs: Mesalazine
    Synonyms: Mild to moderate distal ulcerative colitis
  4. Indication

    Resistance or intolerance to prior therapy

    go.drugbank.com/conditions/DBCOND0101935
    Drugs: Bexarotene · Bosutinib · Dasatinib · Doxorubicin
    Synonyms: Resistance or intolerance to prior therapy
  5. Indication

    Resistant to or intolerant of hydroxyurea

    go.drugbank.com/conditions/DBCOND0102253
    Drugs: Ruxolitinib
    Synonyms: Resistant to or intolerant of hydroxyurea
  6. Drug

    Omeprazole

    go.drugbank.com/drugs/DB00338
    ApprovedInvestigationalVet approved

    Originally approved by the FDA in 1989, omeprazole is a _proton-pump inhibitor_, used to treat gastric acid-related disorders. … These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid.

    Products: OMEPRAZOL AL T 20, OMEPRAZOL AL T 40
  7. Drug

    Ganciclovir

    go.drugbank.com/drugs/DB01004
    ApprovedInvestigational

    Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.

    Products: İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN LİYOFİLİZE TOZ, 1 ADET, TAMOVIR 500 MG IV INFÜZYON IÇIN LIYOFILIZE TOZ IÇEREN FLAKON, 1 ADET
  8. Drug

    Trastuzumab

    go.drugbank.com/drugs/DB00072
    ApprovedInvestigational

    In November 2023, trastuzumab was also approved by the EMA under the brand name Herwenda.[L49339] … It displays biosimilar properties as Herceptin according to clinical data.

    Products: HERCEPTIN 150 MG İNFÜZYONLUK ÇÖZELTİ İÇİN KONSANTRE TOZ, KANJİNTİ 150 MG İNFÜZYONLUK ÇÖZELTİ HAZIRLAMADA KULLANILACAK KONSANTRE İÇİN TOZ, 1 ADET
  9. Drug

    Human C1-esterase inhibitor

    go.drugbank.com/drugs/DB06404
    ApprovedInvestigational

    The disease is characterized by acute attacks of painful, and in some cases, fatal swelling of several soft tissues or edema, which may last up to five days when untreated.[L16586, L16606] … The primary function of endogenous C1INH is to regulate the activation of the complement and contact system pathways.

    Products: CİNRYZE 500 IU/5 ML IV ENJEKSİYONLUK ÇÖZELTİ İÇİN LİYOFİLİZE TOZ VE ÇÖZÜCÜ, 2 ADET
  10. Drug

    Factor IX Complex (Human)

    go.drugbank.com/drugs/DB11330
    ApprovedInvestigational

    As the product Kcentra, Factor IX Complex is also indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients

    Products: BERIPLEX P/N 250 IU ENJEKSİYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ VE ÇÖZÜCÜ, 1 ADET, BERIPLEX P/N 500 IU ENJEKSİYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ VE ÇÖZÜCÜ, 1 ADET